📣 VC round data is live. Check it out!
- Public Comps
- ABVC BioPharma
ABVC BioPharma Valuation Multiples
Discover revenue and EBITDA valuation multiples for ABVC BioPharma and similar public comparables like Above Food, Local Bounti, Steakholder Foods, Moolec Science and more.
ABVC BioPharma Overview
About ABVC BioPharma
ABVC BioPharma Inc is a clinical-stage biopharmaceuticals company with an active pipeline of six drugs and one medical device (ABV-1701/Vitargus) under development. Its drug products focus on utilizing its licensed technology to conduct proof-of-concept trials through Phase II of the clinical development process. The firm specializes in botanically based solutions that deliver high efficacy with low toxicity for improved health outcomes.
Founded
2015
HQ

Employees
19
Website
Sectors
Financials (FY)
EV
$32M
Valuation Multiples
Start free trialABVC BioPharma Financials
ABVC BioPharma reported last fiscal year revenue of — and negative EBITDA of ($7M).
In the same fiscal year, ABVC BioPharma generated — in gross profit, ($7M) in EBITDA losses, and had net loss of ($8M).
Revenue (LTM)
ABVC BioPharma P&L
In the most recent fiscal year, ABVC BioPharma reported revenue of — and EBITDA of ($7M).
ABVC BioPharma is unprofitable as of last fiscal year, with gross margin of —, EBITDA margin of —, and net margin of —.
Financial data powered by Morningstar, Inc.
ABVC BioPharma Stock Performance
ABVC BioPharma has current market cap of $30M, and enterprise value of $32M.
Market Cap Evolution
ABVC BioPharma's stock price is $1.15.
ABVC BioPharma share price increased by 11.7% in the last 30 days, and decreased by 16.1% in the last year.
ABVC BioPharma has an EPS (earnings per share) of $-0.30.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $32M | $30M | 0.0% | 11.7% | -8.1% | -16.1% | $-0.30 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialABVC BioPharma Valuation Multiples
ABVC BioPharma trades at (4.4x) EV/EBITDA.
EV / Revenue (LTM)
ABVC BioPharma Financial Valuation Multiples
As of May 26, 2026, ABVC BioPharma has market cap of $30M and EV of $32M.
ABVC BioPharma has a P/E ratio of (3.8x).
Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified ABVC BioPharma Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.


ABVC BioPharma Margins & Growth Rates
ABVC BioPharma Margins
ABVC BioPharma Growth Rates
Data powered by FactSet, Inc. and Morningstar, Inc.
ABVC BioPharma Operational KPIs
ABVC BioPharma's revenue per employee in the last FY averaged $0.0M, while opex per employee averaged $0.4M for the same period.
Data powered by FactSet, Inc. and Morningstar, Inc.
ABVC BioPharma Competitors
ABVC BioPharma competitors include Above Food, Local Bounti, Steakholder Foods, Moolec Science, Planethic Group, Next Meats Holdings, Modern Plant Based Foods, Jyong Biotech, Oatly and Beyond Meat.
Most ABVC BioPharma public comparables operate across Plant-Based Food.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| Last FY | LTM | 2027E | Last FY | LTM | 2027E | |
| 0.5x | — | (4.5x) | — | |||
| 10.8x | 10.8x | (13.4x) | — | |||
| — | — | (0.5x) | — | |||
| 0.7x | — | (2.2x) | — | |||
| 1.3x | — | (6.0x) | — | |||
| — | — | — | — | |||
| 6.1x | — | (5.6x) | — | |||
| — | — | (87.1x) | — | |||
This data is available for Pro users. Sign up to see all ABVC BioPharma competitors and their valuation data. Start Free Trial | ||||||
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout ABVC BioPharma
| When was ABVC BioPharma founded? | ABVC BioPharma was founded in 2015. |
| Where is ABVC BioPharma headquartered? | ABVC BioPharma is headquartered in United States. |
| How many employees does ABVC BioPharma have? | As of today, ABVC BioPharma has over 19 employees. |
| Who is the CEO of ABVC BioPharma? | ABVC BioPharma's CEO is Uttam Yashwant Patil. |
| Is ABVC BioPharma publicly listed? | Yes, ABVC BioPharma is a public company listed on Nasdaq. |
| What is the stock symbol of ABVC BioPharma? | ABVC BioPharma trades under ABVC ticker. |
| When did ABVC BioPharma go public? | ABVC BioPharma went public in 2004. |
| Who are competitors of ABVC BioPharma? | ABVC BioPharma main competitors include Above Food, Local Bounti, Steakholder Foods, Moolec Science, Planethic Group, Next Meats Holdings, Modern Plant Based Foods, Jyong Biotech, Oatly, Beyond Meat. |
| What is the current market cap of ABVC BioPharma? | ABVC BioPharma's current market cap is $30M. |
| Is ABVC BioPharma profitable? | No, ABVC BioPharma is not profitable. |
| How many companies ABVC BioPharma has acquired to date? | ABVC BioPharma hasn't acquired any companies yet (or none have been disclosed publicly). |
| In how many companies ABVC BioPharma has invested to date? | ABVC BioPharma hasn't invested in any companies yet (or none have been disclosed publicly). |
See public comps similar to ABVC BioPharma
Lists including ABVC BioPharma
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.